Because (44) PARP1 dependent cell death plays a pivotal role in the progress of stroke, pharmacological inhibition of PARP1 can eliminate inflammation, protect neurons, regulate the translocation of apoptosis-inducing factor, and improve recovery of neurological functions in ischemic stroke (45, 46). This evidence concerns the gene PARP1 and stroke disorder.